05/07/2026
WHY SHORT CHAINS OF AMINO ACIDS ARE NATURALLY OCCURRING — AND WHY CALLING THEM HARMFUL IS PREPOSTEROUS
Your body is literally built on amino acids and short peptide chains. Every day, you consume proteins from food (steak, eggs, whey, collagen, or even vegetables), and your digestive system breaks them down into individual amino acids and short peptide fragments. These are absorbed, circulated, and used as raw materials for muscle repair, hormone production, immune function, and cellular signaling.
Even without eating, your body constantly turns over its own proteins — breaking down old tissues and recycling the amino acids into new short peptide messengers. Natural examples include:
Endogenous growth-hormone-releasing fragments produced by your hypothalamus
Small peptides involved in tissue repair and inflammation control
Signaling molecules like enkephalins or endorphins — all short amino acid chains
The peptides we use therapeutically — CJC-1295, Ipamorelin, and Cibinetide (ARA-290) — are simply lab-sequenced versions of these same natural building blocks. They are made from the identical L-amino acids your body already recognizes, produces, and metabolizes every single second of your life.
Suggesting that these short chains could cause mysterious long-term side effects is preposterous. It would be like claiming that eating high-quality food or taking a clean whey-protein or BCAA supplement will eventually harm you. Your body doesn’t treat them as foreign invaders — it treats them as familiar fuel and signals. Peptidases (enzymes that exist everywhere in your blood, tissues, and cells) rapidly break these short chains down into single amino acids within minutes to hours. Those amino acids are either used for repair and energy or safely excreted. There is no accumulation, no toxic metabolites, and no long-term “build-up” the way some synthetic drugs create.
Decades of research on amino acid supplementation (BCAAs, EAAs, collagen peptides) confirm this safety profile. Millions of athletes and health-conscious adults use them daily with zero evidence of long-term harm. The therapeutic peptides in our protocols are the same concept — just more precisely targeted. When they come from licensed compounding pharmacies and are monitored with labs, they function as next-level, bio-identical supplementation. The fear-mongering usually comes from conflating them with GLP-1 drugs or unmonitored gray-market products — not from the actual biochemistry.
